NervGen Pharma Corp. Common stock
$1.94
▼ 0.08
(-3.96%)
Volume: 343,192
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
37
- 21d momentum -12.2%
- RSI 43
🎯
Pullback
62
- Near lower Bollinger band
- -10.2% vs 20MA
💎
Value
58
- -69% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)43.4
MACD-0.042
MA trendMixed
ATR6.69%
21d mom.-12.2%
63d mom.+3.7%
vs 20MA-10.2%
RVOL(20)0.59×
52w low · 2
52w high · 6
-69.2% from 52-week high
20d support 2
· resistance 2
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap—
PER—
PBR—
PSR—
EPS—
ROE—
ROA—
Dividend yield—
Debt/Equity—
EV/EBITDA—
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -5.37% | -12.22% | +3.74% | -46.99% | -23.62% | -67.01% |
Valuation and profitability in USD. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -16.74%, daily vol 4.12%. NervGen Pharma Corp. Common stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.